Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 2 Diabetes Mellitus(T2DM)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06703684
What this trial is testing

TCM Syndrome Differentiation of T2DM & MetS

Who this might be right for
Diabetes Mellitus, Type 2Metabolic Syndrome
Hong Kong Baptist University 470
Not applicableUnknownNCT06007014
What this trial is testing

Efficacy and Safety of Chiglitazar Added to Glargine in Patients With Type 2 Diabetes

Who this might be right for
Efficacy and Safety of Chiglitazar Sodium in the Treatment of T2DM PatientsMetformin Combined With Insulin Glargine in the Treatment of Type 2 Diabetes Patients Who Still Have Poor Hypoglycemic Effect128 Patients Were Randomly Assigned 1:1+4 more
Yanbing Li 128
Early research (Phase 1)Study completedNCT02113163
What this trial is testing

PK Study Comparing Metformin Eicosapentaenoate to a Combined Dose of Metformin Hydrochloride and Ethyl Ester EPA

Who this might be right for
Diabetes Mellitus, Non-Insulin-DependentHypertriglyceridemia
Thetis Pharmaceuticals LLC 32
Early research (Phase 1)Study completedNCT01427257
What this trial is testing

Pharmacokinetic Profile of Two Formulations of PB1023 Following Single Subcutaneous Injection in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
PhaseBio Pharmaceuticals Inc. 10
Post-approval studies (Phase 4)Study completedNCT02694263
What this trial is testing

Canagliflozin (Invokana™) vs. Standard Dual Therapy Regimen for T2DM During Ramadan

Who this might be right for
Diabetes Mellitus, Type 2
University of Leicester 25
Not applicableNot Yet RecruitingNCT06960512
What this trial is testing

Precision Lifestyle Interventions Guided by Continuous Glucose Monitoring: Impact on Glycemic Outcomes in Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
He Eye Hospital 200
Not applicableLooking for participantsNCT07083336
What this trial is testing

Liver Fat as a Dietary Target of the Chinese Medical Nutrition Therapy (CMNT) Diet for Treating Type 2 Diabetes With Nonalcoholic Fatty Liver Disease (Version 3.0)

Who this might be right for
Type 2 Diabetes MellitusMetabolic Dysfunction-associated Steatotic Liver Disease
State Key Laboratory of Subhealth Intervention Technology 120
Not applicableStudy completedNCT06803836
What this trial is testing

Inflammatory Response and Gingival iNOS Levels in Diabetic vs. Non-Diabetic Periodontitis Patients

Who this might be right for
PeriodontitisType 2 DiabetesGlycemic Control
Ondokuz Mayıs University 118
Large-scale testing (Phase 3)Study completedNCT04218734
What this trial is testing

DBPR108 and Metformin Hydrochloride Combination Therapy in Patients With T2DM

Who this might be right for
Type 2 Diabetes Mellitus
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 214
Not applicableLooking for participantsNCT07512934
What this trial is testing

Assessment of Pancreatic Dysfunction in Patients With Type 2 Diabetes

Who this might be right for
Pancreatogenic Diabetes MellitusType 2 Diabetes Mellitus (T2DM)Exocrine Pancreatic Insufficiency (EPI)
West Kazakhstan Marat Ospanov Medical University 310
Not applicableStudy completedNCT06664099
What this trial is testing

Comparison of Weight Loss and Nutritional Deficiency After One Anastomosis Gastric Bypass at 150, 170, and 200 cm From the Duodenojejunal Junction

Who this might be right for
ObesityNutritional DeficiencyType 2 Diabetes Mellitus (T2DM)+1 more
Cairo University 60
Early research (Phase 1)Study completedNCT03646721
What this trial is testing

Evaluate the Safety, Tolerability, PK and PD of DA-1241 in Healthy Male Subjects and Subjects With T2DM

Who this might be right for
Diabetes Mellitus, Type 2
Dong-A ST Co., Ltd. 108
Not applicableNot Yet RecruitingNCT07708610
What this trial is testing

Preadmission GLP-1 Receptor Agonist Plus SGLT2 Inhibitor Use and Early Outcomes After Pneumonia Hospitalization in Adults With Type 2 Diabetes

Who this might be right for
PneumoniaType 2 Diabetes Mellitus (T2DM)
Chung Shan Medical University 71,775
Early research (Phase 1)Study completedNCT02009488
What this trial is testing

Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Diabetes Mellitus, Type 2
Janssen Research & Development, LLC 59
Not applicableLooking for participantsNCT07051005
What this trial is testing

Feasibility of a Tailored Online Self-compassion Intervention

Who this might be right for
Type 1 Diabetes MellitusType 2 Diabetes Mellitus (T2DM)
Canterbury Christ Church University 50
Not applicableLooking for participantsNCT07728669
What this trial is testing

Digital Dietary Intervention for Patients Receiving GLP-1 Receptor Agonist Therapy

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Obesity (Disorder)Overweight+1 more
Kazakh Academy of Nutrition 120
Early research (Phase 1)Study completedNCT07372118
What this trial is testing

Bioequivalence Study to Compare Empagliflozin / Metformin 25 mg/ 1000 mg Extended-Release Tablet Versus Synjardy XR Tablets 25mg/1000mg in Fast Condition

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Humanis Saglık Anonim Sirketi 32
Not applicableStudy completedNCT03907423
What this trial is testing

Rosuvastatin on Diabetic Patients Treated With Glimepiride/Metformin

Who this might be right for
Diabetes Mellitus, Type 2
Rehab Werida 70
Early research (Phase 1)Study completedNCT02302443
What this trial is testing

A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12470

Who this might be right for
Diabetes Mellitus
Hanmi Pharmaceutical Company Limited 100
Post-approval studies (Phase 4)Study completedNCT00948168
What this trial is testing

Effect of Exenatide on Glucose Homeostasis Determinants in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 34
Next Page